NCT04433910View on ClinicalTrials.gov

A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

August 30, 2020

Primary Completion Date

January 21, 2021

Study Completion Date

March 25, 2022

Conditions
COVID-19
Interventions
DRUG

Convalesscent Plasma

Transfusion

Trial Locations (16)

13353

University Hospital Berlin, Charite, Berlin

17487

University Hopsital Greifswald, Greifswald

23538

Universtity Hospital Schleswig-Holstein, Lübeck

24105

Universtity Hospital Schleswig-Holstein, Kiel

35033

University Hospital Marburg, Marburg

35392

University Hospital Gießen, Giessen

40225

University Düsseldorf, Düsseldorf

60590

University Hopsital Frankfurt, Frankfurt

66421

Saarland University Hospital, Homburg

68167

University Hospital Mannheim, Mannheim

70174

Klinikum Stuttgart, Stuttgart

72076

University Hospital Tübingen, Tübingen

76133

Städtisches Klinikum Karslruhe, Karlsruhe

79110

University Hospital Freiburg, Freiburg im Breisgau

89081

University Hospital Ulm, Ulm

01307

Universitiy Hospital Dresden, Dresden

All Listed Sponsors
lead

Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen

OTHER

NCT04433910 - A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19 | Biotech Hunter | Biotech Hunter